At Memorial Sloan Kettering (MSK), we're not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we're driving excellence and improving outcomes. We're treating cancer, one patient at a time. Join us and make a difference every day.
In compliance with applicable State regulatory authorities, COVID-19 vaccination is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical or fully remote exemption. Requests for medical exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster two months after completion of a primary vaccination series for COVID-19. Because vaccine-induced immunity can wane over time, MSK continues to strongly urge all staff to get a COVID-19 booster as soon as they become eligible to maintain their protective immunity for a longer period.
Positions are available for postdoctoral fellows in the research group of Melinda Diver at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City to elucidate molecular mechanisms of ion channels involved in pain sensing.
We are particularly interested in how ion channels involved in somatosensation and pain signaling perform their specialized biological functions, including their critical roles in pathophysiology. Our approach is comprehensive, combining high-resolution structure determination, biochemical and biophysical approaches, electrophysiology, and high-throughput drug screening, thereby facilitating a broad understanding of the function of 'pain' channels, as well as the development of new therapeutics for debilitating pain syndromes.
The Diver laboratory is equipped with state-of-the art facilities for membrane protein biochemistry, electrophysiology, and structural biology. Our research program is supported by access to high quality facilities for single-particle cryo-electron microscopy (cryo-EM) including a FEI Titan Krios at MSKCC and additional microscopes, resources, and training at the New York Structural Biology Center, which includes NCCAT.
MSKCC is ideally located within the vibrant Tri-institutional community, alongside Weill Cornell Medical College and Rockefeller University, on Manhattan's Upper East Side. The community is committed to research training and offers an exciting and stimulating environment for biomedical research. Housing and childcare assistance are available.
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes. For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.